CMPI

Checkmate Pharmaceuticals, Inc. Common Stock

Delisted

CMPI was delisted on the 27th of May, 2022.

36 hedge funds and large institutions have $236M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 4 closing their positions.

Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
0.64%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
3
Increased
13
Reduced
8
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$55K +$44K +3,000 +400%
UBS Group
27
UBS Group
Switzerland
$43K +$33.6K +2,302 +355%
Wells Fargo
28
Wells Fargo
California
$39K +$18.8K +1,303 +93%
SO
29
STRS Ohio
Ohio
$29K +$10.2K +700 +54%
TRCT
30
Tower Research Capital (TRC)
New York
$19K -$78.6K -5,486 -81%
Citigroup
31
Citigroup
New York
$15K +$11.4K +777 +321%
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$12K +$8.47K +564 +240%
Legal & General Group
33
Legal & General Group
United Kingdom
$8K
AIP
34
Ameritas Investment Partners
Nebraska
$6K
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$5K +$5K +336 New
AIG
36
American International Group
New York
$43 -$1 -84 -3%
CCM
37
CAAS Capital Management
New York
-$518K -44,966 Closed
ZP
38
Zimmer Partners
New York
-$288K -25,000 Closed
Goldman Sachs
39
Goldman Sachs
New York
-$145K -12,600 Closed
MCM
40
Moore Capital Management
New York
-$115K -10,000 Closed